Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer
about
How do kinases contribute to tonicity-dependent regulation of the transcription factor NFAT5?Nrf2 and Notch Signaling in Lung Cancer: Near the CrossroadEffects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.Exosomal miRs in Lung Cancer: A Mathematical Model.Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in miceSKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancerCXCR2 Inhibition in Human Pluripotent Stem Cells Induces Predominant Differentiation to Mesoderm and Endoderm Through Repression of mTOR, β-Catenin, and hTERT Activities.The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas.Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLCThe dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells.Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian CancerComparative Network Analysis of Patients with Non-Small Cell Lung Cancer and Smokers for Representing Potential Therapeutic Targets.Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells.Acquired resistance to PI3K/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysis.Akt1 Stimulates Homologous Recombination Repair of DNA Double-Strand Breaks in a Rad51-Dependent Manner.A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation.Implications of KRAS mutations in acquired resistance to treatment in NSCLC.Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy.A-674563, a putative AKT1 inhibitor that also suppresses CDK2 activity, inhibits human NSCLC cell growth more effectively than the pan-AKT inhibitor, MK-2206.Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study.The nuclear transcription factor RelB functions as an oncogene in human lung adenocarcinoma SPC-A1 cells.Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 geneKrukovine Suppresses KRAS-Mutated Lung Cancer Cell Growth and Proliferation by Inhibiting the RAF-ERK Pathway and Inactivating AKT PathwayDownregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer
P2860
Q26770757-2CB0C132-01FE-48F6-B1E0-7277FDCA119EQ28066915-BAD9CCCA-3772-47C2-B20A-3EB158F1C42AQ36034972-5A325583-BA48-48F2-B015-CA8EF0FEB288Q36230579-05D1298F-CC27-48D0-B655-82D2BA7E2191Q36544718-4230E644-5A7F-4371-86BE-2D03F1D155D7Q36738620-9895BBA2-9028-4B4F-929E-AB0D52CAAD67Q37061263-386CE60A-90EA-4826-A6EA-0114ED487575Q37520257-7AD79519-5CAD-4F91-AFB2-23CD378A6C57Q37645002-8E48118B-3DB9-4F83-AECC-CF9544AE0805Q41582917-9E13596F-6CB6-4303-AD4A-6245B4971088Q42070616-4D1EAB36-4556-41FC-A909-748D59A9E989Q42144129-54182D15-7E2E-426C-9392-ED185CA74380Q44646012-7F8CE845-6F17-4422-96D2-6DB35AB45705Q47101798-B607198A-D7CD-4C49-AC16-38E228064EEFQ47143132-4BEFF92B-CB1C-4464-9152-B1E2053B1FC1Q47383621-F2D34418-9472-4E85-BFAA-AF7B1B73CCF0Q47716658-9F78436F-35AE-49F0-AABD-5B54FFDFB553Q49787333-39A8C371-DCFF-4CE7-AD29-43B713AD5118Q52649775-A4B34C9B-A601-4F49-B399-986FECD9777CQ52731012-688B25C4-E1D3-432D-A028-F53E760E72CFQ54978516-983AF54B-B4A6-4A1D-93F5-1671171CD059Q55512935-4A432B9F-E384-4BF8-ADA9-633A9723E078Q58573280-A7CFA538-0EBD-4486-BC11-6BAF792DB6C5Q58719649-209EADB0-C1B9-493D-80B2-C332F359E900Q58796935-E8AF8C4C-8B37-4A86-BD24-341DA899F7DB
P2860
Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Phosphatidylinositol 3-kinase- ...... in non-small cell lung cancer
@ast
Phosphatidylinositol 3-kinase- ...... in non-small cell lung cancer
@en
type
label
Phosphatidylinositol 3-kinase- ...... in non-small cell lung cancer
@ast
Phosphatidylinositol 3-kinase- ...... in non-small cell lung cancer
@en
prefLabel
Phosphatidylinositol 3-kinase- ...... in non-small cell lung cancer
@ast
Phosphatidylinositol 3-kinase- ...... in non-small cell lung cancer
@en
P2860
P1476
Phosphatidylinositol 3-kinase- ...... in non-small cell lung cancer
@en
P2093
Po Yee Yip
P2860
P304
P356
10.3978/J.ISSN.2218-6751.2015.01.04
P577
2015-04-01T00:00:00Z